• ALS News

  NPT520-34 for ALS Treatment Proceeds to Phase 1 Trial

  Posted by Community Member on May 15, 2019 at 1:27 pm

  

  Neuropore has launched a Phase 1 trial testing NPT520-34 to assess its safety, tolerability, and pharmacokinetic properties in healthy volunteers. Read more about the trial here.

  What do you think of this news?

  Community Member replied 1 Member · 0 Replies
• 0 Replies

Log In to Reply